Dacryocystorhinostomy
Dacryocystorhinostomy (DCR) is a drainage procedure designed to bypass the site of nasolacrimal duct obstruction by forming a fistula between the lacrimal sac and the nasal cavity. This procedure is performed in patients who have chronic epiphora or dacryocystitis secondary to complete or partial obstruction of the nasolacrimal duct. It is applicable to patients whose upper and lower canaliculi are patent but contraindicated in cases of suspected lacrimal sac malignancy. Additionally, a DCR should not be performed on a patient with acute dacryocystitis. One should wait until the infection has been cleared and for an opportunity to reassess the patient’s symptoms and patency of the lacrimal drainage system.
PREOPERATIVE EVALUATION
Before surgery, a thorough nasal speculum examination should be performed to rule out any abnormalities, such as deviated septum, polyps, or tumor, which may compromise the success of the procedure. One should also verify that there is adequate space adjacent to the planned internal ostium.
To reduce bleeding, the patient should refrain from taking aspirin, aspirin-containing products, anti-inflammatory agents and anticoagulants (both prescription and over-the-counter supplements) for at least 2 weeks prior to surgery. Preoperative medical evaluation and clearance for both surgery and cessation of blood-thinning medication is recommended when medically indicated (i.e., recent stroke, cardiac stents, history of thromboembolic disease). In patients with systemic hypertension, optimal blood pressure control before surgery is mandatory because vasoconstrictors are used during this procedure. Patients with discharge from the sac are instructed to massage the sac and use topical antibiotics for several days before surgery.
SURGICAL TECHNIQUE
Anesthesia and skin marking
A DCR procedure can be performed under either general or local anesthesia. Local anesthesia combined with mild sedation is preferred because it has the advantages of fewer postoperative side effects and wider patient acceptance. Regardless of anesthetic choice, nasal packing with “pseudococaine” (150 ml lidocaine 4% HCl topical solution, 45 ml oxymetazoline HCl 0.05%, 1.8 g sodium chloride granular USP, benzalkonium chloride 17% solution, 1 drop peppermint oil and 1 drop sterile green food color)-moistened cotton strips and subcutaneous injection of a lidocaine solution containing epinephrine should be given to facilitate hemostasis. Improved visualization of anatomy from meticulous control of hemostasis is the key to success in this procedure.
Upon arrival in the operating room, the patient’s nasal cavity on the involved side is sprayed with the “pseudococaine” solution. The solution will vasoconstrict and anesthetize the vascular mucosa to minimize discomfort during subsequent packing. After 5 minutes, the anterosuperior nasal cavity adjacent to the lacrimal fossa is packed with a strip of cotton gauze moistened with the “pseudococaine” solution. Nasal packing should be performed with the aid of a fiberoptic headlight, nasal speculum, and bayonet forceps.
The patient is then prepared and draped while the surgeon scrubs. The face is left exposed to provide adequate access to the nose for nasal inspection and silicone stent retrieval during the procedure.
Skin incision
A skin incision over the preplaced marking is made with a size 15 Bard-Parker blade. The incision should be no deeper than the subcutaneous fascia. With the skin edges tented up by forceps, the remaining strands of superficial fascia are cut with Stevens scissors. All bleeding points and subcutaneous vessels are cauterized with a wet-field bipolar cautery.